Specifically, AMs derived from patients with COPD exhibited significantly higher MMP9 activity compared to those derived from non-smokers and healthy smokers, with decreased TIMP1 production [72]. This evidence concerns the gene MMP9 and chronic obstructive pulmonary disease.